Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biontech Se ADR (BNTX)

Biontech Se ADR (BNTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 60,066,604
  • Shares Outstanding, K 242,517
  • Annual Sales, $ 550,960 K
  • Annual Income, $ 17,360 K
  • 60-Month Beta -1.16
  • Price/Sales 110.20
  • Price/Cash Flow 919.24
  • Price/Book 9.15
Trade BNTX with:

Options Overview Details

View History
  • Implied Volatility 61.00%
  • Historical Volatility 61.44%
  • IV Percentile 8%
  • IV Rank 9.80%
  • IV High 139.19% on 11/02/20
  • IV Low 52.50% on 04/09/21
  • Put/Call Vol Ratio 0.72
  • Today's Volume 9,835
  • Volume Avg (30-Day) 20,884
  • Put/Call OI Ratio 1.04
  • Today's Open Interest 101,166
  • Open Int (30-Day) 101,406

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 11.79
  • Number of Estimates 5
  • High Estimate 18.09
  • Low Estimate 8.07
  • Prior Year -1.03
  • Growth Rate Est. (year over year) +1,244.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
230.03 +7.67%
on 10/01/21
374.85 -33.93%
on 09/16/21
-107.57 (-30.28%)
since 09/15/21
3-Month
222.35 +11.39%
on 07/16/21
464.00 -46.62%
on 08/10/21
+26.60 (+12.03%)
since 07/15/21
52-Week
75.35 +228.73%
on 10/28/20
464.00 -46.62%
on 08/10/21
+157.30 (+174.04%)
since 10/15/20

Most Recent Stories

More News
The Zacks Analyst Blog Highlights: Southwest Airlines, Delta Air Lines, Moderna, Pfizer and BioNTech

The Zacks Analyst Blog Highlights: Southwest Airlines, Delta Air Lines, Moderna, Pfizer and BioNTech

PFE : 41.49 (-0.43%)
DAL : 40.99 (-0.51%)
LUV : 50.36 (-2.23%)
MRNA : 324.21 (-2.31%)
BNTX : 247.68 (-1.06%)
Best Single Trading Day in Months for Dow, Nasdaq, S&P

The indexes had been trying to turn around a steep drop to the start of the week, and finally managed on Thursday.

GS : 406.07 (+3.80%)
PFE : 41.49 (-0.43%)
PLD : 136.98 (+0.92%)
DAL : 40.99 (-0.51%)
LUV : 50.36 (-2.23%)
JBHT : 190.55 (+8.74%)
MRNA : 324.21 (-2.31%)
BNTX : 247.68 (-1.06%)
BioNTech SE Sponsored ADR (BNTX) Gains But Lags Market: What You Should Know

BioNTech SE Sponsored ADR (BNTX) closed at $250.33 in the latest trading session, marking a +0.37% move from the prior day.

BNTX : 247.68 (-1.06%)
Will Moderna's (MRNA) COVID-Led Rally Continue in 2022?

Moderna's (MRNA) COVID-19 vaccine has boosted the company's prospects significantly since early 2020. Strong performance of the vaccine is likely to continue in 2022. However, competition seems to be on...

SNY : 48.85 (+0.54%)
PFE : 41.49 (-0.43%)
MRNA : 324.21 (-2.31%)
BNTX : 247.68 (-1.06%)
Has BioNTech SE Sponsored (BNTX) Outpaced Other Medical Stocks This Year?

Is (BNTX) Outperforming Other Medical Stocks This Year?

BNTX : 247.68 (-1.06%)
Vaxart (VXRT) Starts Recruitment in Oral COVID-19 Vaccine Study

Vaxart (VXRT) commences recruiting subjects in its mid-stage study for its oral vaccine tablet for COVID-19. It will begin dosing in the United States later this month.

REGN : 553.24 (-0.43%)
PFE : 41.49 (-0.43%)
VXRT : 6.94 (-3.61%)
BNTX : 247.68 (-1.06%)
Moderna (MRNA) Gets EMA Authorization for SpikeVax Third Dose

Moderna (MRNA) gets authorization for the third dose of its COVID-19 vaccine, Spikevax, for use in immunocompromised individuals in Europe.

JNJ : 161.30 (+0.74%)
PFE : 41.49 (-0.43%)
MRNA : 324.21 (-2.31%)
BNTX : 247.68 (-1.06%)
J&J (JNJ) Seeks FDA Authorization for COVID-19 Booster Jab

J&J (JNJ) submits data to the FDA to support an authorization for the booster dose of its single-shot COVID-19 vaccine.

JNJ : 161.30 (+0.74%)
PFE : 41.49 (-0.43%)
MRNA : 324.21 (-2.31%)
BNTX : 247.68 (-1.06%)
Biotech Stock Roundup: MRNA's Vaccine Update, GILD's CAR T Therapy Label Expansion

Regulatory and pipeline updates from bigwigs like Moderna (MRNA) and Gilead (GILD) have been the biotech sector's few key highlights during the past week.

REGN : 553.24 (-0.43%)
BMY : 58.36 (+1.14%)
PFE : 41.49 (-0.43%)
GILD : 67.63 (-0.76%)
MRNA : 324.21 (-2.31%)
BNTX : 247.68 (-1.06%)
Technology Stocks Pull Stock Indexes Sharply Lower

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Friday closed down -1.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.94%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 4,471.37 (+0.75%)
SPY : 445.87 (+0.76%)
$DOWI : 35,294.76 (+1.09%)
DIA : 352.85 (+1.07%)
$IUXX : 15,146.92 (+0.63%)
QQQ : 368.94 (+0.63%)
NVDA : 218.62 (+0.53%)
ADSK : 291.19 (+0.70%)
MCHP : 72.78 (+0.41%)
ASML : 789.40 (+1.43%)
GOOG : 2,833.50 (+0.19%)
AMAT : 131.59 (-0.36%)
ILMN : 409.93 (+0.45%)
ALGN : 589.61 (-1.36%)
MRNA : 324.21 (-2.31%)
NVAX : 161.95 (-4.59%)
BNTX : 247.68 (-1.06%)
FB : 324.76 (-1.15%)
DVN : 40.10 (+0.80%)
FANG : 108.28 (-0.51%)
PSX : 81.22 (-1.14%)
MRO : 16.18 (+0.25%)
HAL : 26.01 (+4.88%)
MRK : 78.33 (unch)
ZNZ21 : 130-225 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

BioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany.

See More

Key Turning Points

3rd Resistance Point 259.41
2nd Resistance Point 256.11
1st Resistance Point 251.89
Last Price 247.68
1st Support Level 244.37
2nd Support Level 241.07
3rd Support Level 236.85

See More

52-Week High 464.00
Fibonacci 61.8% 315.53
Fibonacci 50% 269.67
Last Price 247.68
Fibonacci 38.2% 223.81
52-Week Low 75.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar